Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia

    ... Able to adhere to the study visit schedule and other protocol requirements ...

    Clinical Trial last updated 06/06/2016 - 1:30pm.

  2. T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    ... The primary aim of this protocol is to evaluate if the one-year survival is significantly improved ...

    Clinical Trial last updated 05/03/2016 - 11:43am.

  3. Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic

    ... Able and willing to comply with the requirements of the protocol . Able to understand and willing to sign an IRB-approved ... by the allowed medications permitted in the study protocol that would preclude safe and complete study participation, as ...

    Clinical Trial last updated 04/29/2016 - 4:33pm.

  4. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... The trial proposed is a three arm phase II treatment protocol designed to investigate the safety and efficacy of risk-adjusted ...

    Clinical Trial last updated 04/28/2016 - 8:44am.

  5. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

    ... previously will not be allowed unless approved by the Protocol Officer or one of the Protocol Chairs. Patient unable to comply with the treatment protocol ...

    Clinical Trial last updated 06/06/2016 - 1:36pm.

  6. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

    ... previously will not be allowed unless approved by the Protocol Officer or one of the Protocol Chairs. Planned use of anti-thymocyte globulin (ATG) or ...

    Clinical Trial last updated 06/06/2016 - 1:59pm.

  7. Safety Study of Cord Blood Units for Stem Cell Transplants

    ... if the transplant will occur under an IND research protocol . In addition to the licensure guidance, the FDA published a ...

    Clinical Trial last updated 04/27/2016 - 2:25pm.

  8. Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

    ... than when robust hematologic improvement is achieved ( protocol 90-H-0146). The explanation for partial recovery and relapse are ... by mouth for three months, eleven (44%) patients met protocol criteria of clinically meaningful hematologic responses, without ...

    Clinical Trial last updated 04/25/2016 - 2:47pm.

  9. Transplants With Unlicensed Preserved Cord Blood

    ... centers Patients who are enrolled on another IND protocol to access the unlicensed CBU(s) Patients whose selected ...

    Clinical Trial last updated 05/09/2016 - 3:47pm.

  10. Nonmyeloablative Haploidentical Transplant Followed by MLN9708

    ... at one year post-transplant. It is hoped that under this protocol , this rate will be at most 25%. Thus the investigators ...

    Clinical Trial last updated 04/29/2016 - 1:05pm.